Features Biotechnology

Jim Kastenmayer – Viela Bio

Imagine strolling through a park splashed with the greens, yellows and reds of trees, grass and flowers. The gravel or woodchips crunch underfoot as you enjoy exercise, sunshine and good health. And suddenly, you can’t see well or have trouble walking. It could be an attack of a terrifying and debilitating condition called neuromyelitis optica […]

Jeffrey C. Pepe – Silverback Therapeutics

Talk to Jeffrey C. Pepe and it’s obvious he’s as much scientist as legal boss of Seattle-based biopharmaceutical startup Silverback Therapeutics, advancing potent first-in-kind immunotherapies. He’ll put in layman’s terms the complex immunotherapies Silverback anticipates bringing into the clinic later this year. If all goes well—and that’s an issue considering how COVID-19 threatens to set […]

Shawnte Mitchell – Aptevo Therapeutics

Will the data provide strong, tangible results or prove inconclusive? Will patients feel positive, negative or no side effects? And, most essentially, will the new therapies serve as a cure for the insidious disease that is cancer? Right now is a critical time for Aptevo Therapeutics and its several oncology therapies. With many potential treatments […]

LATEST EDITION

Summer I 2020

READ NOW

GET VANGUARD IN YOUR INBOX.

  • * We’ll never share your email or info with anyone.
  • This field is for validation purposes and should be left unchanged.